MAPS has just sent to a Canadian Institutional Review Board (IRB) a protocol for a randomized, active placebo-controlled, double-blind study of MDMA-assisted psychotherapy for people with PTSD to take …
Shortly after drafting the Memorandum of Understanding with MAPS, RCMP psychologist Jeff Morley realized that it would not be possible for him to obtain permission from the RCMP for him to be the Principal …
The MAPS-sponsored study in Israel evaluating MDMA-assisted psychotherapy for subjects with war-and terrorism-related posttraumatic stress disorder (PTSD) has full government approval and is now in the …
Dr. Peter Oehen’s MAPS-sponsored study evaluating MDMA-assisted psychotherapy for subjects with chronic posttraumatic stress disorder (PTSD) has been making swift progress. Last Thursday, March 8, …
Contact Jag Davies, MAPS Director of Communications (831) 336-4325 or jag@maps.org For Immediate Release February 13, 2007 DEA Judge Recommends End to Government Obstruction of Medical Marijuana Research …
One morning in 2006, MAPS founder and executive director Rick Doblin, Ph.D., learned of a violent crime that had occurred a few houses away from the MAPS office in Ben Lomond, California. “I starting …
Dr. Peter Oehen conducted the second experimental MDMA-assisted psychotherapy session with the second subject in his ongoing MAPS-sponsored MDMA-assisted therapy pilot study for subjects with treatment-resistant …
Principal Investigator Peter Oehen, M.D., officially initiated the Swiss MAPS-sponsored pilot study evaluating MDMA-assisted psychotherapy for subjects with treatment-resistant posttraumatic stress disorder …
Dr. Peter Oehen’s MAPS-sponsored MDMA/PTSD protocol has full government approval and the first subject began the screening process last week. The Ethics Committee (the Swiss IRB equivalent, which …
The Israeli Import Permit and the Swiss Export Permit have now been approved. On Thursday, August 3rd, in the midst of war, about 5 grams of MDMA arrived in Israel for MAPS’ MDMA/PTSD study, imported …
Switzerland’s DEA equivalent, the BAG, has officially approved Dr. Peter Oehen’s MAPS-sponsored study evaluating MDMA-assisted psychotherapy as a treatment for subjects suffering from treatment-resistant …
Switzerland’s FDA equivalent, SwissMedic, has now fully approved Dr. Peter Oehen’s MAPS-sponsored MDMA/PTSD study. The protocol design had already been approved, and earlier this week we received …
